Khurram Jamil, Chief Medical Officer at GALECTIN THERAPEUTICS INC (GALT), sold 7,557 shares at $3.14 ($24K) on 2026-06-23, disclosed to the SEC on 2026-06-25.
Scheduled sale ($24k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GALT | SELL | 2026-05-28 | $2K | — | Filing → |
| GALT | SELL | 2026-01-06 | $465K | — | Filing → |
| GALT | SELL | 2026-01-05 | $33K | — | Filing → |